A recombinant defective adenoviral agent expressing anti-bcl-2 ribozyme promotes apoptosis of bcl-2-expressing human prostate cancer cells

Thambi Dorai*, Harris Perlman, Kenneth Walsh, Ahmad Shabsigh, Erik T. Goluboff, Carl A. Olsson, Ralph Buttyan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Fingerprint Dive into the research topics of 'A recombinant defective adenoviral agent expressing anti-bcl-2 ribozyme promotes apoptosis of bcl-2-expressing human prostate cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences